These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21748595)

  • 1. The impact of acetylation and deacetylation on the p53 pathway.
    Brooks CL; Gu W
    Protein Cell; 2011 Jun; 2(6):456-62. PubMed ID: 21748595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of radiosensitivity by p53 and its acetylation.
    Zhang J; Shen L; Sun LQ
    Cancer Lett; 2015 Jul; 363(2):108-18. PubMed ID: 25911240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain.
    Mellert H; Sykes SM; Murphy ME; McMahon SB
    Cell Cycle; 2007 Jun; 6(11):1304-6. PubMed ID: 17534149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage activates p53 through a phosphorylation-acetylation cascade.
    Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
    Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
    Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
    Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks.
    Benkirane M; Sardet C; Coux O
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):98-103. PubMed ID: 20074043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
    Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
    BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Regulators of p53 Acetylation.
    Nagasaka M; Miyajima C; Aoki H; Aoyama M; Morishita D; Inoue Y; Hayashi H
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
    Magrini R; Russo D; Fronza G; Inga A; Menichini P
    J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
    Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
    BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death.
    Bock FJ; Tanzer MC; Haschka MD; Krumschnabel G; Sohm B; Goetsch K; Kofler R; Villunger A
    Sci Rep; 2015 Jun; 5():11268. PubMed ID: 26062895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
    Taira N; Yoshida K
    Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.
    Vaghefi H; Neet KE
    Oncogene; 2004 Oct; 23(49):8078-87. PubMed ID: 15361854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications and activation of p53 by genotoxic stresses.
    Appella E; Anderson CW
    Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stress-responsive gene ATF3 regulates the histone acetyltransferase Tip60.
    Cui H; Guo M; Xu D; Ding ZC; Zhou G; Ding HF; Zhang J; Tang Y; Yan C
    Nat Commun; 2015 Apr; 6():6752. PubMed ID: 25865756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 post-translational modification: deregulated in tumorigenesis.
    Dai C; Gu W
    Trends Mol Med; 2010 Nov; 16(11):528-36. PubMed ID: 20932800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of p21 (Cip1/WAF1) following Tip60-dependent acetylation is required for p21-mediated DNA damage response.
    Lee MS; Seo J; Choi DY; Lee EW; Ko A; Ha NC; Yoon JB; Lee HW; Kim KP; Song J
    Cell Death Differ; 2013 Apr; 20(4):620-9. PubMed ID: 23238566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.
    Wang H; Zhao Y; Li L; McNutt MA; Wu L; Lu S; Yu Y; Zhou W; Feng J; Chai G; Yang Y; Zhu WG
    J Biol Chem; 2008 Feb; 283(5):2564-74. PubMed ID: 17977830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.